See more : NuVista Energy Ltd. (NUVSF) Income Statement Analysis – Financial Results
Complete financial analysis of Yungjin Pharm. Co., Ltd. (003520.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yungjin Pharm. Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Tetragon Financial Group Limited (TFG.L) Income Statement Analysis – Financial Results
- LG Electronics Inc. (066575.KS) Income Statement Analysis – Financial Results
- Schulz S.A. (SHUL3.SA) Income Statement Analysis – Financial Results
- evertex fabrinology limited (1470.TW) Income Statement Analysis – Financial Results
- CStone Pharmaceuticals (2616.HK) Income Statement Analysis – Financial Results
Yungjin Pharm. Co., Ltd. (003520.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.yungjin.co.kr
About Yungjin Pharm. Co., Ltd.
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 234.90B | 218.38B | 196.07B | 208.46B | 220.52B | 186.41B | 195.01B | 193.13B | 170.20B | 167.57B | 156.62B | 137.69B | 112.11B | 116.32B | 103.38B | 110.87B | 109.66B |
| Cost of Revenue | 162.78B | 153.65B | 138.13B | 135.00B | 140.74B | 124.97B | 126.17B | 121.89B | 105.38B | 106.39B | 99.61B | 89.30B | 67.38B | 64.77B | 60.04B | 64.94B | 70.43B |
| Gross Profit | 72.12B | 64.73B | 57.94B | 73.46B | 79.77B | 61.44B | 68.84B | 71.25B | 64.82B | 61.18B | 57.01B | 48.39B | 44.72B | 51.54B | 43.34B | 45.92B | 39.23B |
| Gross Profit Ratio | 30.70% | 29.64% | 29.55% | 35.24% | 36.18% | 32.96% | 35.30% | 36.89% | 38.08% | 36.51% | 36.40% | 35.14% | 39.89% | 44.31% | 41.92% | 41.42% | 35.78% |
| Research & Development | 11.91B | 14.36B | 13.26B | 15.07B | 13.51B | 11.99B | 13.93B | 12.66B | 11.79B | 9.31B | 8.58B | 6.62B | 4.27B | 4.16B | 3.43B | 3.25B | 3.77B |
| General & Administrative | 2.43B | 2.74B | 4.04B | 4.60B | 5.24B | 5.14B | 5.29B | 4.97B | 4.47B | 4.46B | 4.26B | 3.95B | 3.91B | 4.58B | 4.80B | 6.41B | 8.37B |
| Selling & Marketing | 21.62B | 19.69B | 19.77B | 20.04B | 19.68B | 16.36B | 18.28B | 15.98B | 13.66B | 14.56B | 13.88B | 14.67B | 13.56B | 11.89B | 19.14B | 17.84B | 7.67B |
| SG&A | 24.05B | 22.43B | 23.81B | 24.65B | 24.92B | 21.51B | 23.58B | 20.95B | 18.12B | 19.02B | 18.14B | 18.62B | 17.47B | 16.47B | 23.94B | 24.25B | 16.05B |
| Other Expenses | 33.05B | 35.30B | 34.74B | 33.36B | 31.36B | 250.29M | 722.42M | 299.55M | 91.80M | 467.79M | 7.43B | 1.30B | 18.75B | 28.83B | 16.52B | -2.06B | -2.50B |
| Operating Expenses | 69.47B | 72.10B | 71.81B | 73.08B | 69.79B | 63.63B | 65.81B | 65.79B | 59.77B | 54.20B | 50.10B | 45.12B | 40.49B | 49.47B | 43.89B | 44.26B | 46.67B |
| Cost & Expenses | 231.79B | 225.74B | 209.94B | 208.08B | 210.53B | 188.60B | 191.98B | 187.68B | 165.16B | 160.59B | 149.71B | 134.42B | 107.87B | 114.24B | 103.92B | 109.20B | 117.10B |
| Interest Income | 11.32M | 2.69M | 2.43M | 2.58M | 2.26M | 135.81M | 93.50M | 35.07M | 70.96M | 100.45M | 78.40M | 42.79M | 155.86M | 187.56M | 13.17M | 139.33M | 229.86M |
| Interest Expense | 2.88B | 736.57M | 208.97M | 253.25M | 427.37M | 272.63M | 463.03M | 787.47M | 869.88M | 660.90M | 1.19B | 1.39B | 1.05B | 2.40B | 2.86B | 2.76B | 4.33B |
| Depreciation & Amortization | 8.69B | 7.78B | 7.38B | 7.78B | 7.65B | 6.64B | 6.60B | 5.83B | 5.86B | 4.91B | 4.90B | 4.63B | 3.97B | 3.65B | 3.44B | 6.68B | 6.23B |
| EBITDA | 7.65B | -14.30B | -6.56B | 8.27B | 17.30B | 4.45B | 9.85B | 11.94B | 11.28B | 12.04B | 17.12B | 8.61B | 8.21B | 4.25B | 1.95B | 7.76B | -4.02B |
| EBITDA Ratio | 3.26% | -6.26% | -3.27% | 4.07% | 8.08% | 2.82% | 5.21% | 5.98% | 6.51% | 7.18% | 11.96% | 6.25% | 7.50% | 5.17% | 2.70% | 6.13% | -3.22% |
| Operating Income | 3.12B | -7.36B | -13.88B | 694.51M | 9.98B | -2.19B | 3.03B | 5.45B | 5.05B | 6.98B | 6.92B | 3.27B | 4.09B | 404.44M | -1.50B | 1.66B | -7.44B |
| Operating Income Ratio | 1.33% | -3.37% | -7.08% | 0.33% | 4.53% | -1.17% | 1.55% | 2.82% | 2.97% | 4.16% | 4.42% | 2.37% | 3.64% | 0.35% | -1.45% | 1.50% | -6.78% |
| Total Other Income/Expenses | -7.04B | -15.45B | -266.11M | -140.19M | -579.70M | -4.46B | -240.59M | -129.96M | -497.00M | -514.00M | 4.12B | -669.60M | -892.48M | -2.22B | -2.85B | -3.34B | -7.15B |
| Income Before Tax | -3.92B | -22.81B | -14.14B | 241.27M | 9.40B | -6.65B | 2.79B | 5.32B | 4.55B | 6.46B | 11.04B | 2.60B | 3.19B | -1.81B | -4.35B | -1.67B | -14.58B |
| Income Before Tax Ratio | -1.67% | -10.45% | -7.21% | 0.12% | 4.26% | -3.57% | 1.43% | 2.76% | 2.67% | 3.86% | 7.05% | 1.89% | 2.85% | -1.56% | -4.21% | -1.51% | -13.30% |
| Income Tax Expense | -42.35M | -851.73M | -2.56B | 374.39M | 4.37B | -550.60M | 920.67M | 1.12B | 1.16B | 5.55B | -704.21M | 803.92M | 612.39M | 497.09M | -100.86M | 5.06B | -2.33B |
| Net Income | -3.88B | -21.96B | -11.58B | -133.12M | 5.03B | -6.10B | 1.87B | 4.20B | 3.39B | 909.09M | 11.74B | 1.79B | 2.58B | -2.31B | -4.35B | -6.73B | -14.58B |
| Net Income Ratio | -1.65% | -10.06% | -5.91% | -0.06% | 2.28% | -3.27% | 0.96% | 2.18% | 1.99% | 0.54% | 7.50% | 1.30% | 2.30% | -1.98% | -4.21% | -6.07% | -13.30% |
| EPS | -21.00 | -120.08 | -63.33 | -0.73 | 27.50 | -33.36 | 10.00 | 24.00 | 19.00 | 5.00 | 66.00 | 10.00 | 15.00 | -16.00 | -32.84 | -50.60 | -130.49 |
| EPS Diluted | -21.19 | -120.08 | -63.33 | -0.73 | 27.50 | -33.00 | 10.00 | 24.00 | 19.00 | 5.00 | 66.00 | 10.00 | 15.00 | -16.00 | -32.84 | -50.60 | -130.49 |
| Weighted Avg Shares Out | 184.55M | 182.89M | 182.89M | 182.89M | 182.89M | 182.89M | 182.68M | 175.09M | 178.23M | 181.82M | 177.91M | 179.42M | 177.62M | 144.29M | 132.38M | 133.08M | 111.74M |
| Weighted Avg Shares Out (Dil) | 182.89M | 182.89M | 182.89M | 182.89M | 182.89M | 184.88M | 186.77M | 175.09M | 178.23M | 181.82M | 177.91M | 179.42M | 177.62M | 144.29M | 132.38M | 133.08M | 111.74M |
No news found for: 003520.KS
Source: https://incomestatements.info
Category: Stock Reports